Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.
- DOI
- 10.1016/j.esmoop.2021.100270
- Published
- 2021 Oct
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2021.100270,
title = {Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.},
author = {Bordonaro R and Calvo A and Auriemma A and Hollebecque A and Rubovszky G and Saunders MP and Pápai Z and Prager G and Stein A and André T and Argilés G and Cubillo A and Dahan L and Edeline J and Leger C and Cattan V and Fougeray R and Amellal N and Tabernero J},
year = {2021},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2021.100270},
url = {https://doi.org/10.1016/j.esmoop.2021.100270}
}RIS
TY - JOUR TI - Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study. AU - Bordonaro R AU - Calvo A AU - Auriemma A AU - Hollebecque A AU - Rubovszky G AU - Saunders MP AU - Pápai Z AU - Prager G AU - Stein A AU - André T AU - Argilés G AU - Cubillo A AU - Dahan L AU - Edeline J AU - Leger C AU - Cattan V AU - Fougeray R AU - Amellal N AU - Tabernero J PY - 2021 JO - ESMO open DO - 10.1016/j.esmoop.2021.100270 UR - https://doi.org/10.1016/j.esmoop.2021.100270 ER -
APA
R, B., A, C., A, A., A, H., G, R., MP, S., Z, P., G, P., A, S., T, A., G, A., A, C., L, D., J, E., C, L., V, C., R, F., N, A., & J, T. (2021). Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.. ESMO open. https://doi.org/10.1016/j.esmoop.2021.100270
Source records
- pubmed · retrieved 2026-09-26T08:16:07.842Z